148 related articles for article (PubMed ID: 29914080)
21. Molecular subtyping of cancer and nomination of kinase candidates for inhibition with phosphoproteomics: Reanalysis of CPTAC ovarian cancer.
Tong M; Yu C; Zhan D; Zhang M; Zhen B; Zhu W; Wang Y; Wu C; He F; Qin J; Li T
EBioMedicine; 2019 Feb; 40():305-317. PubMed ID: 30594550
[TBL] [Abstract][Full Text] [Related]
22. Thrombospondin-1 might be a therapeutic target to suppress RB cells by regulating the DNA double-strand breaks repair.
Chen P; Yu N; Zhang Z; Zhang P; Yang Y; Wu N; Xu L; Zhang J; Ge J; Yu K; Zhuang J
Oncotarget; 2016 Feb; 7(5):6105-20. PubMed ID: 26756218
[TBL] [Abstract][Full Text] [Related]
23. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases.
Wang S; Nath N; Minden A; Chellappan S
EMBO J; 1999 Mar; 18(6):1559-70. PubMed ID: 10075927
[TBL] [Abstract][Full Text] [Related]
24. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431.
Ahmad N; Gupta S; Mukhtar H
Oncogene; 1999 Mar; 18(10):1891-6. PubMed ID: 10086343
[TBL] [Abstract][Full Text] [Related]
25. Control of DNA replication by protein phosphorylation.
Boulikas T
Anticancer Res; 1994; 14(6B):2465-72. PubMed ID: 7872668
[TBL] [Abstract][Full Text] [Related]
26. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC
Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958
[TBL] [Abstract][Full Text] [Related]
27. Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines.
Crowe DL; Shuler CF
Cell Growth Differ; 1998 Aug; 9(8):619-27. PubMed ID: 9716179
[TBL] [Abstract][Full Text] [Related]
28. Regulatory networks of the retinoblastoma protein.
Lee WH; Chen PL; Riley DJ
Ann N Y Acad Sci; 1995 Mar; 752():432-45. PubMed ID: 7755289
[TBL] [Abstract][Full Text] [Related]
29. The retinoblastoma tumour suppressor in development and cancer.
Classon M; Harlow E
Nat Rev Cancer; 2002 Dec; 2(12):910-7. PubMed ID: 12459729
[TBL] [Abstract][Full Text] [Related]
30. Cooperative control of Crb2 by ATM family and Cdc2 kinases is essential for the DNA damage checkpoint in fission yeast.
Nakamura TM; Moser BA; Du LL; Russell P
Mol Cell Biol; 2005 Dec; 25(24):10721-30. PubMed ID: 16314498
[TBL] [Abstract][Full Text] [Related]
31. Apoptotic and mitogenic stimuli inactivate Rb by differential utilization of p38 and cyclin-dependent kinases.
Nath N; Wang S; Betts V; Knudsen E; Chellappan S
Oncogene; 2003 Sep; 22(38):5986-94. PubMed ID: 12955077
[TBL] [Abstract][Full Text] [Related]
32. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.
Olsen JV; Vermeulen M; Santamaria A; Kumar C; Miller ML; Jensen LJ; Gnad F; Cox J; Jensen TS; Nigg EA; Brunak S; Mann M
Sci Signal; 2010 Jan; 3(104):ra3. PubMed ID: 20068231
[TBL] [Abstract][Full Text] [Related]
33. G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation.
Akiyama T; Sugiyama K; Shimizu M; Tamaoki T; Akinaga S
Jpn J Cancer Res; 1999 Dec; 90(12):1364-72. PubMed ID: 10665655
[TBL] [Abstract][Full Text] [Related]
34. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth.
Smith EJ; Leone G; Nevins JR
Cell Growth Differ; 1998 Apr; 9(4):297-303. PubMed ID: 9563849
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAFII250 kinase activity.
Siegert JL; Rushton JJ; Sellers WR; Kaelin WG; Robbins PD
Oncogene; 2000 Nov; 19(50):5703-11. PubMed ID: 11126356
[TBL] [Abstract][Full Text] [Related]
36. Hyperphosphorylated p107 and p130 bind to T-antigen: identification of a critical regulatory sequence present in RB but not in p107/p130.
Knudsen ES; Wang JY
Oncogene; 1998 Apr; 16(13):1655-63. PubMed ID: 9582013
[TBL] [Abstract][Full Text] [Related]
37. MDC1 is a mediator of the mammalian DNA damage checkpoint.
Stewart GS; Wang B; Bignell CR; Taylor AM; Elledge SJ
Nature; 2003 Feb; 421(6926):961-6. PubMed ID: 12607005
[TBL] [Abstract][Full Text] [Related]
38. Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence.
Alexander K; Hinds PW
Mol Cell Biol; 2001 Jun; 21(11):3616-31. PubMed ID: 11340156
[TBL] [Abstract][Full Text] [Related]
39. S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation.
Leng X; Connell-Crowley L; Goodrich D; Harper JW
Curr Biol; 1997 Sep; 7(9):709-12. PubMed ID: 9285720
[TBL] [Abstract][Full Text] [Related]
40. Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase.
Kitagawa M; Okabe T; Ogino H; Matsumoto H; Suzuki-Takahashi I; Kokubo T; Higashi H; Saitoh S; Taya Y; Yasuda H
Oncogene; 1993 Sep; 8(9):2425-32. PubMed ID: 8395680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
